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Summary 
Leishmania major are intramacrophage parasites whose eradication requires the induction of T 
helper I (Thl) effector cells capable of activating macrophages to a microbicidal state. Interlenkin 
12 (IL-12) has been recently identified as a macrophage-derived  cytokine capable of mediating 
Thl effector call development,  and of markedly enhancing interferon 3' (IFN-3') production by 
T cells and natural killer cells. Infection of macrophages in vitro by promastigotes  of L. major 
caused no induction of IL-12 p40 transcripts,  whereas stimulation using heat-killed Listeria or 
bacterial lipopolysaccharide  induced readily detectable IL-12 mRNA. Using a competitor construct 
to quantitate a number of transcripts,  a kinetic analysis of cytokine induction during the first 
few days of infection by L. major  was performed. All strains of mice examined, including susceptible 
BALB/c  and resistant  C57BL/6,  B10.D2,  and C3H/HeN,  had the appearance of a CD4 + 
population in the draining lymph nodes that contained transcripts  for IL-2, IL-4, and IFN-3' 
(and in some cases, IL-10) that peaked 4 d after infection.  In resistant mice, the transcripts  for 
IL-2, IL-4, and IL-10 were subsequently downregulated, whereas in susceptible BALB/c mice, 
these transcripts were only slightly decreased, and IL-4 continued to be reexpressed at high levels. 
IL-12 transcripts  were first detected in vivo by 7 d after infection,  consistent  with induction 
by intracellular amastigotes. Challenge of macrophages in vitro confirmed that amastigotes, in 
contrast  to promastigotes,  induced IL-12 p40 mKNA. Reexamination of the cytokine mRNA 
at 4 d revealed expression of IL-13 in all strains analyzed, suggesting that IL-2 and IL-13 may 
mediate the IL-12-independent production of IFN-3' during the first days after infection. Leishmania 
have evolved to avoid inducing IL-12 from host macrophages during transmission from the insect 
vector, and cause a striking induction of mRNAs for IL-2,  IL-4, IL-10, and IL-13 in CD4 + 
T  cells. Each of these activities may favor survival of the organism. 
T 
he resistance or susceptibility of inbred strains of mice 
to Le~hmania  major correlates  with the induction of 
parasite-specific Thl or Th2 responses, respectively (1-4). Sus- 
ceptibility is not related to the absence of precursors capable 
of parasite-specific  Thl development, however, since a number 
of immunologic interventions enables such mice to heal and 
develop protective Thl cells (5-9). Such interventions must 
be given within the first week of infection in order that redirec- 
tion of the CD4 subset response can be accomplished; inter- 
ventions at later times are unsuccessful. These studies sug- 
gest a critical early period after infection in which Thl or 
Th2 effector subsets become established. 
Although several experimental systems suggest a role for 
the type of APCs (10) or MHC dass lI haplotypes  (11) in 
the developmental regulation of Thl or Th2 cells, recent data 
using limiting dilution analysis (12) and transgenic TCR mice 
(13, 14) suggest that cytokines themselves may be the most 
significant  determinants  in  the  maturation  of  CD4 + 
precursors to Thl or Th2 phenotypes. An extensive analysis 
of CD4 + T cells responding during the course of L. major 
infection was consistent with this model. Immunodominant 
CD4 + cells of both the Thl and Th2 phenotype used com- 
parable TCILs, consistent with their evolution from common 
precursors (15). This analysis suggests that the cytokine milieu 
that occurs during the initial 1-2 wk after infection plays 
a major role in shaping the subsequent development of pro- 
tective Thl or noncurative Th2 cells. In vitro studies have 
identified a potentially important role for IL-12 (16, 17) in 
mediating Thl cell development.  Indeed, treatment of sus- 
ceptible BALB/c mice with recombinant IL-12 mediates cure 
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cytokines (18,  19),  and neutralization  of IL-12 leads to an 
adverse outcome in resistant mice (19).  This effect may be 
mediated through induction of IFN-3' (18), and can be nega- 
tively regulated by IL-10 (13).  Although  neutralization  of 
IFN-'), impedes the development of cure (8, 20), IFN-~/itself 
is not capable of mediating sustained Thl cell development 
in susceptible mice (8, 21). IL-4 has been implicated in Th2 
development (13,  14,  16,  22-24) and inhibition  of Thl de- 
velopment (25) in in vitro studies. Neutralization of IL-4 in 
infected BALB/2 mice induces curative Thl cell development 
(8). IL-2 is required for IL-4 production (24, 26), and neu- 
tralization of IL-2 was also capable of reversing susceptibility 
in the L.  major model (27).  It should be noted that  these 
responses are specific to L. major;  infection of BALB/c mice 
with Candida albicans leads to the development of protective 
Thl  responses (28). 
Based on these considerations,  we undertook a detailed anal- 
),sis of the cytokine response after the interaction of L. major 
with its host cell, the macrophage, in vitro, and during the 
early periods after infection in vivo. Rather than rely on re- 
stimulation of bulk lymphoo/tes in vitro (29) or analysis of 
limiting dilution assays (30, 31), we have employed a system 
of competitive quantitative reverse transcriptase-PCR  (RT- 
PCR) (32) to analyze the cytokine response in defined cell 
populations after parasite challenge.  This method has allowed 
us to identify, several novel features of the immunopathogen- 
esis of murine leishmaniasis and to delineate the critical in- 
tervals during which the Thl/Th2 switch occurs in this model. 
Matcriah  and Methods 
Animals and Parasites.  6-8-wk-old BALB/c, C57BL/6, B10.D2, 
C3H/HeN, and C.B-17/scid (SCID) mice were obtained from The 
Jackson Laboratory (Bar Harbor, ME) and housed in the Univer- 
sity of California, San Francisco (UCSF)animal futility. Infections 
were performed with promastigotes of L. major (strain WHOM/ 
IR/-/173) grown in M199 media (UCSF Cell Culture Facility) 
supplemented with 30% fetal bovine serum and antibiotics. Metacy- 
clic organisms were isolated by negative selection after incubation 
of stationary-phase cultures with peanut lectin-coated beads (Sigma 
Chemical Co., St. Louis, MO) as described (33). In designated ex- 
periments, log-phase procyclic organisms were collected after 48 h 
of culture. Animal experiments used only metacyclics, which rep- 
resent the mature infectious stage of the promastigotes  (34, 35). 
Animals were injected with 5  x  10  s organisms into each hind 
footpad in groups of three-to-five mice for each experimental point. 
Groups of coinfected BALB/c mice were maintained beyond the 
early time points of analysis to establish the virulence of the in- 
ocula. Control groups of animals received sham injections using 
the same volume of balanced salt solution. Designated mice were 
treated with mAb GK1.5 (anti-CD4)  at the time of infection as 
described (7). Amastigotes were purified after disruption of footpad 
tissues from 6-wk-infeaed BALB/c mice and centrifugation through 
a Percoll gradient (Pharmacia, Inc., Piscataway, NJ) as described (7). 
Macrophages and Cell Lines.  Bone marrow macrophages were 
established as described (36). Briefly, femurs from BALB/c and 
C57BL/6 mice were isolated and the marrow evacuated using a 
1-ml tuberculin syringe and 27-gange needle filled with balanced 
salt solution.  Cells were grown in complete DME H21 (UCSF 
Cell Culture Facility) containing L cell-conditioned  media (30% 
vol/vol), antibiotics, and 10% FCS (Hyclone Laboratories, Logan, 
LIT) for I wk until uniform monolayers of macrophages were es- 
tablished. After washing, stimuli were added at the following con- 
centrations:  metacyclic or procyclic L. major, 2-20 organisms per 
macrophage; amastigotes,  1-10 organisms per macrophage, LPS 
(Escherichia coli 055:B5; Sigma Chemical Co.), 50 ng/ml; heat-killed 
Listeria monocytogenes (HKLM)  1, 108 CFU equivalents/m1. After 
6 or 24 h, monolayers were washed with warm balanced salt solu- 
tion, and the cells were removed from the wells by flushing with 
RNAzol (Biotecx, Houston, TX). 
Collection of Cells and Tissue.  At designated periods after infec- 
tion,  the popliteal LN and footpads were flash frozen in liquid 
nitrogen,  pulverized to a fine powder, and placed in RNAzol. For 
analysis of cell subsets, popliteal LN were excised, teased to single 
cell suspensions,  and incubated  with  designated  mAbs against 
CD4 + (GK1.5; Becton-Dickinson  & Co., Mountain  View, CA), 
CD8 + (YTS 169.4; Caltag  Laboratories, San Francisco, CA), or 
NKI.1 (PK 136; Pharmingen, San Diego, CA). Ceils were selected 
in a magnetic field using the appropriate secondary mAbs coupled 
to ferrous beads (Advanced Magnetics, Inc., Cambridge,  MA) as 
described (2). Isolations were carried out entirely at 4~  The pu- 
rity of the designated sdections exceeded 90% in all groups as as- 
sessed by FACS  |  analysis (Becton Dickinson  & Co.) in select ex- 
periments.  Selection by this method resulted in no induction  of 
cytokine transcripts  in resting lymphocyte populations. 
Competitive Quantitative RT-PCR.  Total RNA was extracted 
using RNAzol according to the manufacturer's directions. Speci- 
mens were quantitated both by optical density readings and inten- 
sity ofethidium staining on agarose gels. Reverse transcription was 
performed  using  murine  Moloney leukemia virus  RT (GIBCO 
BRL, Bethesda,  MD) and random  hexamer primers  (Promega, 
Madison, WI) as described (15, 32). PCR was performed using 
a multiple cytokine-containing competitive construct as described 
in detail dsewhere (32). Briefly, aliquots of eDNA were first assayed 
for levels of the constitutively expressed gene, hypoxanthine-guanine 
phosphoribosyltransferase (HPRT), by phcing equal concentrations 
of the competitor construct  in each reaction and examining the 
ratio of competitor-to-wild-type  band intensity after amplification 
with HPRT-specitic primers. At the number of cycles performed, 
this visual inspection could discern differences as small as 1.25-fold 
(32). Adjustments were made in the amount of  expe~aental cDNAs 
needed to standardize the HPRT levels to comparable levels among 
all groups. These adjusted vohmes of eDNA were then used to 
quantitate  cytokine levels using a fixed concentration  of compet- 
itor in each reaction in the presence of the cytokine-specific  primers. 
The primers used for amplification were as described (32) with the 
addition  of the  following:  macrophage  inflammatory  protein 
lo~  (MIP-lc~):  5~ 
3'-GGCATTCAGTTCCAGGTCAGTGA~  IL-13:  5'-CTTGCT- 
TGCCTTGGTGGTCTCGC;  3 '-GCAGTTTTGTTATAAAGT- 
~T.  Cytokine analyses were repeated and the HPRT levels 
were reestablished at the end of each experiment to confirm their 
reprodudbility.  In this assay, separation of the amplification prod- 
ucts after electrophoresis on a 2.5%  ethidium-stained agarose gel 
allows the discrimination of the larger competitor construct from 
the unknown, wild-type cDNAs that migrate farther in the gel. 
For most experiments, the ~nces  in band intensities between 
the wild-type and competitor amplifications between groups allowed 
1 Abbreviations used in this paper: iNOS, inducible nitric oxide syathase; 
HKLM, heat-killed Listeria monocytogenes; HPR.T, hypoxanthine-guanine 
phosphoribosyl-tramferase;  MIP-lot, macrophage inflammatory protein-lot. 
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selected experiments, including the kinetic analyses,  precise quanti- 
tation was achieved  using standard  titrations of  the competitor against 
a constant cDNA input and used to normalize transcript levels to 
expression in resting tissues (32). 
Results 
Leishmania major  Promastigotes  Evade Induction of  Macmphage 
Cytokines In Vitra  Leishmania  invade and replicate only within 
macrophages in the host. Macrophages can serve as the source 
of cytokines such as IL-10 and IL-12 that modulate the de- 
velopment of CD4 + subsets (13, 16). Bone marrow macro- 
phages from BALB/c and C57BL/6 mice were isolated and 
incubated for 24 h with metacyclic  or procyclic promastigotes 
of  L. major, heat-killed Listeria or LPS (Fig.  1). Both HKLM 
and LPS were potent inducers of mKNA for IL-10,  IL-12 
(as assessed by upregulation of p40 subunit expression [37, 
38]), MIP-lot, TNF-ot, and inducible nitric oxide synthase 
(iNOS). In contrast, neither the metacyclic nor procyclic forms 
of L. major induced any of these mKNA from macrophages 
under these conditions, with the exception of small but con- 
sistent increases  in TNF-c~. None of these stimuli induced 
the appearance of TGF-3 transcripts significantly above the 
resting level. Variation of the inocula of promastigotes such 
that 30-90%  of macrophages were infected with multiple 
amastigote forms at the conclusion of the assay or earlier anal- 
),sis at 6 h  after infection resulted in no differences in this 
pattern of cytokine transcription (data not shown). Similar 
results were obtained using the P388.D1  and J774 macro- 
phage cell lines (data not shown). 
Induction of Crtokine  Gene Transcription by Leishmania In 
Viva  Susceptible BALB/c and resistant C57BL/6 mice were 
infected in the hind footpads with metacyclic L. major pro- 
mastigotes and killed immediately or 2, 4, 7, or 14 d later. 
Analysis of cytokine mKNA levels in whole LN by quantita- 
tive RT-PCR revealed a highly stereotyped pattern (Fig. 2); 
no cytokines were induced at  these periods after injection 
with balanced salt solution. Both strains of mice exhibited 
a burst of IL-2 and IL-4 mKNA between 2 and 4 days after 
infection. Peak levels of IL-4 mRNA were usually higher in 
BALB/c mice (up to 16-fold) than in C57BL/6 (up to eight- 
fold), but were comparable in some experiments at 4 d. By 
7 d,  there was a marked decline in  IL-2 and IL-4 mRNA 
in both groups of mice, although the decline in IL-4 was 
consistently less in BALB/c. By 14 d, IL-4 mRNA levels were 
reestablished at high levels in the BALB/c mice, whereas ex- 
pression essentially returned to baseline levels in C57BL/6 
animals. IL-2 mRNA closely followed IL-4 mRNA levels 
in C57BL/6  mice. 
Figure  1.  Induction of cytokine mKNA by Leishmania in host macro- 
phages. BALB/c and C57BL/6 bone marrow-derived macrophages  were 
incubated for 24 h in media alone, or challenged with heat-killed Listeria 
(HKLM), bacterial lipopulysaccharide  (LPS), or metacyclic or procyclic 
promastigotes of  L. major. Monolayers were washed and the KNA purified 
and used for RT-PCR.  The input cDNAs were adjusted to yield com- 
parable ratios of the competitor (upper band in each reaction) to wild-type 
(lower band in each reaction) intensities in the amplification reaction for 
the constitutively  expressed product, I'IPRT (bottom),  as resolved on a 2.5% 
ethidium-stained agarose  gal. These input cDNAs were used in subse- 
quent RT-PCK reactions using the designated oligomers for cytokines or 
inducible nitric oxide synthase (/NOS). IL-12 transcripts represent the in- 
ducibh p40 component of IL-12. HPKT levels were assayed again at the 
conclusion of the e~periment to establish  the reliability of the cDNA 
volumes.  Results are representative  of five comparable experiments. 
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Figure  2.  Cytokine mRNA in the draining LN after infection with 
metacyclic L. major.  BALB/c (top) and C57BL/6 (bottom)  mice were killed 
at designated time points after infection and the dr~inlng LN mRNA levels 
for the designated cytokines were assayed using RT-PCR. The kinetics 
of transcriptional changes for each gem were expressed relative to the levels 
expressed in the LN of uninfected animals, that were assigned a value of 
one. The cDNA concentrations examined at each time point were stan- 
dardized by equalizing the HPRT mRNA levels. Note the vertical scale 
in the BALB/c  group extends one order of magnitude higher than the 
C57BL/6 group. The results represent one of two comparable experiments. 
Variations between replicates within each experiment were <10%. Levels  of IFN-7  rose  steadily  in  both  groups,  but  the 
BALB/c mice consistently maintained an earlier rise as com- 
pared to a late sustained increase in resistant C57BL/6 mice. 
C57BL/6  mice had negligible increases  in IFN-7 mKNA 
until 7 d after infection, coincident with the decrease in IL-4 
mlLNA. BALB/c mice displayed a steady incremental rise in 
IL-10 mRNA  from  days 4  through  14,  whereas  resistant 
C57BL/6  mice had reproducible downregulation  of IL-10 
transcripts between 4 and 7 d, followed by a slow return to 
basdine,  uninfected levels. 
The 11..-4 Burst at 4 d Is Characteristic of the Early Immune 
Response to L. major.  To determine whether other resistant 
strains  of mice exhibited the same induction of cytokines at 
4 d after infection, cytokine mP-,NA expression in infected 
BALB/c  mice  was  compared  to  expression  in  infected 
C57BL/6, C3H/HeN,  and B10.D2 strains (Fig. 3). All in- 
fected animals displayed a burst of IL-4 and IL-2 mKNA ex- 
pression at 4 d, with at least fivefold elevations in all resistant 
strains tested. IFN-  7 mRNA levels were more variable,  with 
highest levels in BALB/c and C3H/HeN mice,  and lowest 
levels in  C57BL/6  animals. 
Origin of  lL-2 and IL-4 mRNA in CD4 + Cells.  To assess 
the contribution by T cells to these cytokine transcripts,  SCID 
mice were infected with L. major and the draining LN popu- 
lations harvested at 4 d and used to examine cytokine mKNA 
levels  (Fig.  4).  BALB/c mice,  congenic with  SCID  except 
for a portion of chromosome 12 (39), were analyzed concur- 
rently.  As compared to infected BALB/c mice,  SCID mice 
expressed  no  detectable  transcripts  for  IL-2  or  IL-4,  had 
markedly decreased levels of IL-10 mKNA, and demonstrated 
slightly enhanced levels of IFN-3' mKNA.  These data were 
consistent with the interpretation  that  IL-2 and IL-4 were 
derived from T  cells,  IL-10 was derived primarily  from T 
cells,  and IFN-'), could be derived from a non-T cell com- 
partment, presumably NK calls, previously demonstrated to 
be an  important  source of IFN-3' in  this  disease (40). 
Figure 4.  Cytokine  mRNA in SCID 
mice infected with L. major. Groups of 
three BALB/c or congenic SCID mice 
were infected (/NF) with  metacyclic 
L. major  and the LN harvested after 4 d. 
After  I,uri~tion of  gNA, the de~gmted 
cytokine mKNAs were compared by ad- 
justing for comparable  HPKT input, and 
compared to  uninfected BALB/c (N). 
Resting levels  of  these  mKNAs in SCID 
mice were comparable  to the uninfected 
BALB/c group. 
To further delineate the T  cell lineage for these cytokine 
transcripts,  BALB/c mice were depleted of CD4 + T cells at 
the time of infection by treatment with mAb GK1.5 before 
harvesting the LN cells after 4 d of infection (Fig. 5). Treat- 
ment with anti-CD4 abolished cytokine transcripts for IL-2, 
IL-4,  IL-10,  and  IFN-'),,  suggesting  that  CD4  T  cells  are 
required for the expression of these mKNAs.  To quantitate 
cytokine mKNA expression in CD4 + T  cells directly, these 
cells were purified from infected BALB/c and C57BL/6 mice 
using magnetic beads before purification ofmRNA and RT- 
PCR  (Fig.  5).  By this  assay, CD4 +  cells  expressed  all  of 
these cytokine transcripts in both strains of mice, and were 
the major source of IL-2, IL-4, and IL-10. Although CD4 § 
T  cells contributed mRNA for IFN-% the major source of 
these transcripts  occurred in  the CD4-  population  of LN 
ceils.  This population  was identified in infected C57BL/6 
mice as cells expressing the NKI.1 marker by magnetic bead 
selection of CD4 +, CD8 +, and NKI,1 § ceils before mRNA 
purification and RT-PCK for IFN-% By this analysis, IFN-3~ 
expression was greatest in NKI.1 § cells, less in CD4 + calls, 
and  least in  CD8 + cells  (data not  shown). 
By 14 d after infection, purification  of CD4 + T  cells re- 
vealed substantial polarization of cytokine transcripts between 
susceptible BALB/c and resistant C57BL/6 mice, with devated 
IL-4 and IL-10 consistently present in BALB/c cells and devated 
IFN-7 present in C57BL/6 ceils (15,  and data not shown). 
Figure 3.  Cytokine mRNA in susceptible  and resistant mice. Popliteal 
LN from groups of three from naive (N) and infected (/) animals of the 
designated strains were harvested 4 d after infection. Competitive PCK 
was performed  for the designated  cytokines  after standardizing the cDNA 
concentration to the HPKT amplification signal. 
Figure 5.  Cellular sources of 
the early  cytokine  burst in murine 
leishmaniam. Groups  of  five  mice 
injected with L. major  or bahnced 
mk solution  (BSS)  wt~e  asmyed  fiar 
mRNA for the designated cyto- 
kines 4 d after inoculation. The 
an/mah wetr divided  into 
those pir  with anti42D4 
mAb before harvest of the LN, 
and those whose LN cells were 
selected into CD4 § (R,'ILB~ or 
C57BL/6  [Ba'])  or  CD4- 
(BALB/c)  populations  using 
mAbs coupled  to magnetic  beads 
before mRNA ~traction. 
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Figure 6.  Inducrionoflb12p40andIL-DmRNAafterinfectionwith 
L. major. Groups office BALB/c or C57BL/6 mice were inoculated with 
metacydic. L. major and the LN harvested at the designated periods after 
infection. After isolation of mKNA, transcripts were analyzed for expres- 
sion of IL.12 p40 and IL-13 mKNA using RT-PCR. Results were com- 
parable in three  separate experiments. 
In contrast to their distribution at 4 d, the IFN-3~ transcripts 
were contained predominantly in the CD4 + and not the 
CD4-  compartment. 
Footpads were harvested at 2 and 4 d after infection  to 
assess whether significant amounts of these cytokines could 
be detected at earlier periods at the site of parasite inocula- 
tion. None of these transcripts were reliably detected at these 
early periods in tissue, and IL-4 mRNA did not appear at 
the footpad site until day 7 or later after infection in both 
resistant  and susceptible mice (data not shown). 
Delayed Induction of IL-12 In  Vivo Correlates with the Ap- 
pearance of  Amastigotes, which  Induce IL-I2 in Macmphages,  In- 
vestigations of  induction of  IL-12 p40 transcripts in vivo were 
carried out in BALB/c, C57BL/6 and C3H/HeN mice. None 
had detectable induction of IL-12 p40 mtLNA at day 2 or 
4 after infection in 12 separate experiments. A typical experi- 
ment in BALB/c and C57BL/6 mice is shown (Fig. 6). Tran- 
scripts for IL-12 p40 first appeared between 7 and 14 d after 
infection,  and were typically  10-fold higher in BALB/c as 
compared to C57BL/6 mice (data not shown). To test the 
sensitivity of the in vivo assay  for detecting IL-12 p40 mRNA 
induction, BALB/c mice were either left untreated, or in- 
jected with either HLKM or L. major  metacydic promastigotes 
(Fig. 7). Under these conditions, HKLM caused striking in- 
Figure 8.  Amastigotes  of 
L. major  induce IL-12  p40 mRNA. 
Bone  marrow-derived  macro- 
phages were incubated for 24 h in 
media alone or with a 10:1 ratio 
of  L. major  amastigotes or metacy- 
clic promastigotes, or with heat- 
kined  L/ster/a  (HKLM).  RNA  was 
purified and analyzed for induc- 
tion  of  IL-12 p40  mRNA  as 
detailed in the legend to Fig. 1. 
Results  represent  one  of three 
comparable experiments. 
duction of IL-12 p40 and IFN-~/mRNA, and,  in contrast 
to L. major,  suppressed  transcripts for IL-4 below resting levds. 
The delayed appearance of IL-12 transcripts  in vivo, to- 
gether with prior reports demonstrating the capacity of an- 
tibodies to IL-12 to affect adversely the outcome of  infection 
with L. major (19), suggested that tissue amastigotes might 
be responsible for inducing IL-12 p40 mRNA. Amastigotes 
were purified from infected footpad tissues and used to in- 
oculate bone marrow-derived  macrophages in vitro. In con- 
trast to promastigotes,  amastigotes induced IL-12 p40 tran- 
scripts in a manner comparable to HKLM (Fig. 8). Further, 
incubation of  amastigotes, but not promastigotes, with SCID 
splenocytes induced the dose-dependent  release of IFN-y 
(Reiner, S. L., and R. M. Locksley,  unpublished observations), 
consistent  with IL-12 protein release (41). 
IL-12 has been been identified as a major stimulus for IFN-'r 
production from NK cells (41-43). The absence of IL-12 in- 
duction by promastigotes  raised  questions  regarding the 
stimulus for the induction of IFN-~/in the NK population 
before day 7 (40). IL-D is a recently described cytokine that, 
in  human systems, has been demonstrated to  induce the 
production of IFN-3' from NK cells both alone and syner- 
gistically with IL-2 (44). LN were isolated 4 d after infection 
from BALB/c, B10.D2, C57BL/6, and C3H/HeN mice, and 
examined for IL-13 transcripts  using RT-PCK (Fig. 9). In 
each of these mice, IL-13 mRNA could be readily detected; 
peak expression occurred at 4 d (Fig. 6). Examination of  tran- 
scripts using mRNA purified from the CD4 + and CD4- 
cell populations in both infected BALB/c and C57BL/6 mice 
confirmed expression of IL-D mRNA in the CD4 + popu- 
lation at 4 d (data not shown). 
Figure 7.  Inoculation of Le/shman/a  or 
heat-killed  L/sto/a.  Groups  of  three 
BALB/c  mice  were  left  uninfected  (na/~), 
or were  inoculated  in the hind footpads 
with 107 CFU heat-killed  Listeria mono- 
cytog~s  (HK/.M)  or metaqr.lic  L. major, 
killed after 2 d and the popliteal LN cells 
e~amined for levels d  Ib12 p40, IFN  W 
and IL,4 mlLNA using RT-PCR stan- 
dardized to HPRT levels. 
451  Reiner et al. 
Figure 9.  IL-13  mRNA is induced 
4  d  after  infection with L.  major. 
Groups of  five mice of the designated 
strains  were  either  left  uninfected 
(naive) or  infected  with  metacydic 
L.  major and the popliteal LN har- 
vested at  4  d  for  analysis of IL-13 
mRNA  expression using RT-PCR 
standardized  to  HPtLT  (data  not 
shown). Discussion 
Leishmania are intramacrophage parasites whose survival 
requires evasion of CD4-mediated activation of macrophages 
to  a microbicidal  state.  The major cytokine produced by 
CD4 +  T  cells  mediating macrophage  activation  against 
Leishmania is IFN-% and neutralization of IFN-~/renders 
otherwise resistant mice unable to restrict  the progression 
of disease (20). Recently, IL-12 has been implicated in medi- 
ating IFN-~/production by both T cells and NK ceils (43, 
45) and has been demonstrated to play a major role in the 
development of Thl effector CD4 cells (16, 17). As demon- 
strated here, Leishmania promastigotes evade  induction of IL-12 
by macrophages in vitro and during infection in vivo, sug- 
gesting that this organism has evolved to enter macrophages 
using pathways that preclude the host's use of this important 
IFN-3,-inducing pathway. Additional cytoldnes produced by 
macrophages, including MIP-lc~ and IL-10, were similarly 
not induced by this organism, and TNF-~ was only minimally 
induced. Our inability to document the induction of tran- 
scripts for TGF-B suggests that the observed enhancement 
in TGF-/3 production reported by others (46) may reflect post- 
translational regulation. Metacyclic promastigotes of L. major 
enter macrophages primarily using the CR1 (CD35) receptor 
(47), suggesting that cross-linking  of CR1 may not effec- 
tively trigger macrophage cytokine production. This is in 
contrast to organisms such as Listeria or Toxoplasma (which 
use laminin-binding integrin receptors [48]), and the LPS of 
gram-negative organisms (which binds to CD14 [49] or CR3 
[50]), all of which induce IL-12 production from macrophages 
in vitro and in vivo (16, 45, 51). As demonstrated here, one 
consequence of the relatively "silent" entry utilized by Le/sh- 
mania was the failure to transcribe iNOS, an indispensable 
component of the priming of macrophages to an antileish- 
manial state (52, 53). 
Although recombinant IL-12 has been demonstrated to en- 
able susceptible BALB/c mice to heal L. major infection (18, 
19), the data presented here suggest that failure to activate 
IL-12 transcription in vivo does not underlie the genetic sus- 
ceptibility to L. major. IL-12 transcripts  were first detected 
in all strains only seven or more days after infection. Impor- 
tantly, in resistant  strains of mice, generation of IL-12 oc- 
curred at a time after IL-4 and IL-10 became dowuregnlated, 
thus leaving IFN-3' unimpeded in the activation of macro- 
phages.  In contrast,  susceptible  BALB/c mice maintained 
significant levels of ILat and IL-10 during the period of IL-12 
induction, suggesting that IFN-~ produced in this period 
may be incapable of activating macrophages (54-57) or that 
the effects of IL-12 may be significantly attenuated (13). The 
capacity of 1L-12 to cure BALB/c mice (18, 19) and the failure 
of IFN-3, to cure (8), suggests that some of the effects of 
IL-12 may be IFN-3' independent. Similar conclusions have 
been generated in human systems of IL-4-mediated Ig class 
switching (58). 
The observation that polyclonal antisera ag,  lmt IL-12 were 
capable of abrogating control of L major  in resistant C57BL/6 
(19) suggests that IL-12 induced after 7 d is required for max- 
imizing the host control of the parasite. In contrast to the 
promastigotes naturally inoculated by the sandfly vector, the 
tissue amastigotes induced readily detectable transcripts for 
IL-12 p40 when incubated with macrophages in vitro, and 
the appearance of IL-12 transcripts after infection in vivo cor- 
related with the period during which amastigotes rupture 
and spread from infected macrophages. The mechanisms by 
which amastigotes, as opposed to promastigotes, induce IL-12 
remains unknown, although preliminary experiments  sug- 
gest  that the iipophosphoglycan  surface antigen, LPG,  of 
promastigotes  inhibits  the induction of II,-12 from stimu- 
lated macrophages (Reiner, S. L., and R. M. Locksley, un- 
published observations). Promastigotes  ofLeishmania donovani 
were significantly more susceptible to macrophage-mediated 
microbiddal activities than were amastigotes (59), suggesting 
that once transformation occurs, amastigotes are more pre- 
pared for intracdhhr survival. Indeed, persistence of L. major 
amastigotes for prolonged Periods has been documented, even 
in resistant  strains of mice (60, 61). 
In contrast to their relatively silent invasion of macrophages 
in vitro, Leishmania promastigotes  induced broad, Th0-1ike 
(62) cytokine expression in CD4 § T  ceils that peaked 4 d 
after infection. This was true in all strains of mice mined 
and occurred irrespective of healer or nonhealer phenotype. 
Although the patterns of cytokine induction were similar in 
these mice in over 15 experiments,  quantitative  differences 
between strains were consistently noted. This was particu- 
larly true for IFN-3,  mRNA,  for which C3H/HeN  and 
BALB/c mice were consistently  high producers,  whereas 
C57BL/6 mice expressed low levels of this cytokine. These 
quantitative differences did not correlate with outcome of 
infection,  however,  suggesting that  expression  of IFN-~ 
mRNA at early periods after infection does not correlate with 
the healer or nonbealer phenotype. Differences in IFN-~ 
production presumably  reflect differences in the NK com- 
partments between these strains of mice (40). 
The demonstration of induction of a reproducible  Th0 
phenotype at 4 d is consistent with the development of Thl 
and Th2 cells from a common precursor,  as suggested by 
studies of TCK usage in L. major  infection (15) and in modu- 
lation of CD4 subset development in cells from TCK trans- 
genic mice (13, 14). Earlier studies using different methods 
corroborate these findings.  Thus two laboratories  have es- 
tablished the capacity to recover CD4 + T cells that produce 
both IL-4 and IFN~ within the first week after infection 
with L. major from both susceptible and resistant strains (30, 
31). These investigators  used restimulation of isolated LN 
cells followed by limiting dilution analysis to recover secreted 
cytokines from supernatants  generated in vitro, and the hy- 
pothesis was advanced that the failure of BALB/c mice to 
cure correlated with a failure to downregulate the secretion 
of 1I,-4 (31). We have generated similar data using a tran- 
scriptional  approach that avoids potential artifacts induced 
during restimulation in vitro when cells may be isolated from 
the natural mih'en. In contrast, our approach does not docu- 
ment the efficient translation and secretion of these cytokines. 
In agreement with the earlier studies, stimulation of lyre- 
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resistant mice with the mitogen Con A yielded detectable 
IL-4 and IFN-3r by both ELISA and ELISPOT assays in both 
susceptible and resistant  mice (Reiner, S. L., unpublished 
results).  The cytokines expressed by T cells are regulated al- 
most entirely at the transcriptional level (63), and the pres- 
ence of sequences  in the 3'-untranslated regions of these 
mKNAs confers short half-lives on these pleiotropic medi- 
ators of the immune response (64). IL-12 is unusual among 
these cytokines in consisting of a heterodimer. The p35 subunit 
is constitutively expressed in a number of cell types, including 
macrophages (51), but is not efficiently secreted in the ab- 
sence of the p40 subunit (37). The latter is transcriptionally 
induced in macrophages by a number of stimuli and contains 
the typical 3'-untranslated cytokine sequences conferring short 
mKNA half-life (38, 65). No instances in which induction 
of p40 mRNA in macrophages has not resulted in secretion 
of bioactive p35/p40 IL-12 have been described (45). The cor- 
roboration of much of the findings using protein-based assays 
by the transcriptional approach used here suggests the va- 
lidity of this experimental strategy, which has the advantage 
of examining increased numbers of cytokines due to the powers 
of a PCR-based approach. At the same time, some differ- 
ences are apparent in these studies.  Whereas Morris et al. 
(30) could detect IL-4 from lymphocytes from C57BL/6 mice 
at 14 d after infection, we could detect little IL-4 mRNA 
in vivo during this period. Thus, some differences due to 
the  experimental  methodologies, the  site  of inoculation 
(footpads in this study versus base of the tail in the earlier 
study), or our use of selected metacyclic organisms, were ob- 
served. 
The most striking differences between susceptible and resis- 
tant mice in this analysis was the failure of susceptible BALB/c 
mice to downregulate transcripts for IL-4 after their induc- 
tion 4 d after infection. In contrast, resistant  mice down- 
regulated IL-4 transcripts to baseline,  uninfected, levels by 
7-14  d  after  infection.  Such downregulation left  IFN-'y 
mRNA unopposed in resistant mice. These data suggest that 
a number of cytokine transcripts (IL-2, IL-4, and II.-10), with 
the notable exclusion of IFN-3,, have the capacity to be coor- 
dinately downregulated after their induction, and further sug- 
gest that BALB/c mice may have a defect in this regulatory 
pathway. Alternatively, BALB/c mice may appropriately down- 
regulate cytokine transcripts in an early Th0 population of 
ceils that is overtaken by an expanding population of Th2 
ceils between days 2 and 7. 
Two other features of the host response to L. major were 
noteworthy. First, CD4 + T  ceils were the only source of 
IL-2 and IL-4, as assessed in studies of both SCID mice and 
CD4-depleted animals.  Despite similar analysis of footpad 
tissues after infection, we were unable to document the early 
appearance  of IL-4 at  this  site.  This suggests that,  as in 
influenza infection (66),  the initial cytokine transcripts ap- 
pear in the draining regional LN and then subsequently are 
apparent in tissues as sensitized T cells recirculate to the pri- 
mary site of antigenic inoculation. It is still possible  that 
preformed IL-4, as may occur in human mast cells (67), may 
be released in tissues and contribute to the initial cytokine 
burst in the draining LN. Further study will be required to 
address this possibility. Second, CD4 § T cells were required 
for the induction of IFN-3' transcripts, despite the observa- 
tion that the major source of IFN-3r mKNA was in the NK 
population. The evasion of IL-12 induction by promastigotes 
of  Leishmania  suggested  alternative,  T  cell-dependent, 
pathways for IFN-3, production, as demonstrated by the dis- 
appearance of these transcripts after administration of anti- 
CD4 antibody. Studies using human peripheral blood cells 
stimulated with anti-CD3 and PHA have demonstrated that 
",'50% of the IFN-~ produced is due to the endogenous pro- 
duction of IL-12 (45), thus confirming an IL-12-independent, 
T  cell-dependent pathway for IFN-'y production. The ca- 
pacity of IL-D to synergistically enhance IFN-~/production 
from NK cells (44), and the demonstration of IL-13 in Th0 
clones (68), suggested that this cytokine may contribute to 
the induction of IFN-3r transcripts in the NK population, 
perhaps in conjunction with IL-2 (44),  shortly after infec- 
tion with L. major. IL-13 mRNA could be readily detected 
in the CD4 + T  cell population 4  d  after  infection in all 
strains of mice examined. Aside from its role in enhancing 
NK-derived IFN-% IL-13 most dosely resembles IL-4 in its 
activities (44, 68, 69), presumably because of its capacity to 
share components of the IL-4 receptor (70). Further evalua- 
tion of the role of IL-13 in IL-12-independent IFN-'), produc- 
tion will require the development of neutralizing antibodies 
to this recently described cytokine. 
In summary, these studies have elucidated several novel fea- 
tures elicited during the early periods after invasion by Leish- 
mania that may contribute to the survival of this parasite in 
host macrophages. First, Leishmania promastigotes enter mac- 
rophages by a pathway that evades the induction of cytokines 
implicated in orchestrating the cellular immune response, par- 
ticularly IL-12 (71). Second,  a striking burst in IL-4 tran- 
scription occurs in the CD4 + T cell population that peaked 
at 4 d in all strains of mice analyzed.  The simultaneous in- 
duction of IL-2, IL-10, IL-13, and IFN-3, in most strains sug- 
gests that a Th0 population has been stimulated. In contrast 
to resistant  strains,  susceptible BALB/c mice fail to down- 
regulate IL-4 transcription, an observation that may underlie 
the genetic susceptibility of this strain.  Finally, amastigotes 
induce IL-12 from macrophages in a manner similar to other 
intracellular pathogens (16, 45, 51). Stage-specific evasion of 
IL-12  induction delays the development of Thl CD4 + T 
cells to allow transformation of the parasite to a developmental 
form more capable of withstanding the enhanced microbi- 
cidal systems of the activated  macrophage. 
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